Immunogenicity and Safety of COVID-19 Vaccines among People Living with HIV: A Systematic Review and Meta-Analysis
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Immunogenicity and Safety of COVID-19 Vaccines among People Living with HIV: A Systematic Review and Meta-Analysis
Authors
Keywords
-
Journal
Vaccines
Volume 10, Issue 9, Pages 1569
Publisher
MDPI AG
Online
2022-09-21
DOI
10.3390/vaccines10091569
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Safety and immunogenicity of SARS-CoV-2 mRNA-1273 and BNT162b2 vaccines in people living with HIV
- (2022) Manuel González de Aledo et al. AIDS
- Impaired antibody response to COVID-19 vaccination in advanced HIV infection
- (2022) Nolan Hassold et al. AIDS
- Prospective evaluation of COVID-19 vaccine responses across a broad spectrum of immunocompromising conditions: the COVICS study
- (2022) Ghady Haidar et al. CLINICAL INFECTIOUS DISEASES
- Immunogenicity and safety of the BNT162b2 COVID‐19 mRNA vaccine in PLWH: A monocentric study in Bari, Italy
- (2022) Eugenio Milano et al. JOURNAL OF MEDICAL VIROLOGY
- Comparing Immune Responses to Inactivated Vaccines against SARS-CoV-2 between People Living with HIV and HIV-Negative Individuals: A Cross-Sectional Study in China
- (2022) Xiaojie Huang et al. Viruses-Basel
- Impact on HIV-1 RNA Levels and Antibody Responses Following SARS-CoV-2 Vaccination in HIV-Infected Individuals
- (2022) Vera Portillo et al. Frontiers in Immunology
- Durability of ChAdOx1 nCov-19 vaccination in people living with HIV
- (2022) Ane Ogbe et al. JCI Insight
- Frequency of Adverse Events in the Placebo Arms of COVID-19 Vaccine Trials
- (2022) Julia W. Haas et al. JAMA Network Open
- Surrogate neutralisation responses following SARS-CoV-2 vaccination in people living with HIV - comparison between inactivated and mRNA vaccine
- (2022) Ngai Sze Wong et al. AIDS
- Antibody Response in Immunocompromised Patients After the Administration of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine BNT162b2 or mRNA-1273: A Randomized Controlled Trial
- (2022) Benjamin Speich et al. CLINICAL INFECTIOUS DISEASES
- Humoral and Cellular Immune Response Elicited by mRNA Vaccination Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in People Living With Human Immunodeficiency Virus Receiving Antiretroviral Therapy Based on Current CD4 T-Lymphocyte Count
- (2022) Andrea Antinori et al. CLINICAL INFECTIOUS DISEASES
- Reduced Immune Response to Inactivated Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine in a Cohort of Immunocompromised Patients in Chile
- (2022) M Elvira Balcells et al. CLINICAL INFECTIOUS DISEASES
- Safety and Efficacy of a Third Dose of BNT162b2 Covid-19 Vaccine
- (2022) Edson D. Moreira et al. NEW ENGLAND JOURNAL OF MEDICINE
- Covid-19 vaccine immunogenicity in people living with HIV-1
- (2022) Lauriane Nault et al. VACCINE
- Efficacy of covid-19 vaccines in immunocompromised patients: systematic review and meta-analysis
- (2022) Ainsley Ryan Yan Bin Lee et al. BMJ-British Medical Journal
- Safety and immunogenicity of inactivated SARS-CoV-2 vaccines in people living with HIV
- (2022) Ling Ao et al. Emerging Microbes & Infections
- Evaluation of Humoral and Cellular Responses in SARS-CoV-2 mRNA Vaccinated Immunocompromised Patients
- (2022) Matthijs Oyaert et al. Frontiers in Immunology
- Safety and immunogenicity of CoronaVac in people living with HIV: a prospective cohort study
- (2022) Lucas C Netto et al. Lancet HIV
- Safety and Immunogenicity of Inactivated COVID-19 Vaccines Among People Living with HIV in China
- (2022) Xiaoxu Han et al. Infection and Drug Resistance
- Humoral immune responses to COVID-19 vaccination in people living with HIV receiving suppressive antiretroviral therapy
- (2022) Zabrina L. Brumme et al. npj Vaccines
- Reasons for COVID-19 Vaccine Hesitancy Among Chinese People Living With HIV/AIDS: Structural Equation Modeling Analysis
- (2022) Yan Yao et al. JMIR Public Health and Surveillance
- Willingness to pay and financing preferences for COVID-19 vaccination in China
- (2021) Jiahao Wang et al. VACCINE
- Post-acute COVID-19 syndrome
- (2021) Ani Nalbandian et al. NATURE MEDICINE
- Epidemiology and outcomes of COVID-19 in HIV-infected individuals: a systematic review and meta-analysis
- (2021) Paddy Ssentongo et al. Scientific Reports
- The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
- (2021) Matthew J Page et al. BMJ-British Medical Journal
- COVID-19 Vaccine Hesitancy among French People Living with HIV
- (2021) Alexandre Vallée et al. Vaccines
- Safety and antibody response to two-dose SARS-CoV-2 messenger RNA vaccination in persons with HIV
- (2021) Jake A. Ruddy et al. AIDS
- The BNT162b2 mRNA Vaccine Elicits Robust Humoral and Cellular Immune Responses in People Living With Human Immunodeficiency Virus (HIV)
- (2021) Bezawit A Woldemeskel et al. CLINICAL INFECTIOUS DISEASES
- Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in people living with HIV-1
- (2021) Itzchak Levy et al. CLINICAL MICROBIOLOGY AND INFECTION
- Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in HIV infection: a single-arm substudy of a phase 2/3 clinical trial
- (2021) John Frater et al. Lancet HIV
- Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 in people living with and without HIV in South Africa: an interim analysis of a randomised, double-blind, placebo-controlled, phase 1B/2A trial
- (2021) Shabir A Madhi et al. Lancet HIV
- Failure to seroconvert after two doses of BNT162b2 SARS-CoV-2 vaccine in a patient with uncontrolled HIV
- (2021) Emma Touizer et al. Lancet HIV
- Efficacy and Safety of COVID-19 Vaccines in Phase III Trials: A Meta-Analysis
- (2021) Haoyue Cheng et al. Vaccines
- Differences in Post-mRNA Vaccination SARS-CoV-2 IgG Concentrations and Surrogate Virus Neutralization Test Response by HIV Status and Type of Vaccine: a Matched Case-Control Observational Study
- (2021) Matthew A Spinelli et al. CLINICAL INFECTIOUS DISEASES
- Immunogenicity of SARS-CoV-2 infection and Ad26.CoV2.S vaccination in people living with HIV
- (2021) Khadija Khan et al. CLINICAL INFECTIOUS DISEASES
- Qualitative assessment of anti‐SARS‐CoV‐2 spike protein immunogenicity (QUASI) after COVID‐19 vaccination in older people living with HIV
- (2021) Jessica J. Tuan et al. HIV MEDICINE
- Humoral immune response following prime and boost BNT162b2 vaccination in people living with HIV on antiretroviral therapy
- (2021) Nils Jedicke et al. HIV MEDICINE
- Humoral response to SARS-CoV-2 vaccines in people living with HIV
- (2021) Sebastian Noe et al. INFECTION
- Inactivated SARS-CoV-2 vaccines elicit immunogenicity and T-cell responses in people living with HIV
- (2021) Zhengchao Lv et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Humoral response to two doses of BNT162b2 vaccination in people with HIV
- (2021) Line Dam Heftdal et al. JOURNAL OF INTERNAL MEDICINE
- Efficacy and Safety of NVX-CoV2373 in Adults in the United States and Mexico
- (2021) Lisa M. Dunkle et al. NEW ENGLAND JOURNAL OF MEDICINE
- Adverse events of inactivated COVID-19 vaccine in HIV-infected adults
- (2021) Songjie Wu et al. AIDS Research and Therapy
- Safety and efficacy of the mRNA BNT162b2 vaccine against SARS-CoV-2 in five groups of immunocompromised patients and healthy controls in a prospective open-label clinical trial
- (2021) Peter Bergman et al. EBioMedicine
- COVID-19 Vaccination in People Living with HIV (PLWH) in China: A Cross Sectional Study of Vaccine Hesitancy, Safety, and Immunogenicity
- (2021) Ying Liu et al. Vaccines
- Using social and behavioural science to support COVID-19 pandemic response
- (2020) Jay J. Van Bavel et al. Nature Human Behaviour
- Outcomes of COVID-19 related hospitalization among people with HIV in the ISARIC WHO Clinical Characterization Protocol (UK): a prospective observational study
- (2020) Anna Maria Geretti et al. CLINICAL INFECTIOUS DISEASES
- Characteristics of SARS-CoV-2 and COVID-19
- (2020) Ben Hu et al. NATURE REVIEWS MICROBIOLOGY
- COVID-19 in patients with primary and secondary immunodeficiency: The United Kingdom experience
- (2020) Adrian M. Shields et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- COVID-19 Related Medical Mistrust, Health Impacts, and Potential Vaccine Hesitancy Among Black Americans Living With HIV
- (2020) Laura M. Bogart et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial
- (2020) Yanjun Zhang et al. LANCET INFECTIOUS DISEASES
- Vaccination in the adult patient infected with HIV: a review of vaccine efficacy and immunogenicity
- (2019) Firas El Chaer et al. AMERICAN JOURNAL OF MEDICINE
- RoB 2: a revised tool for assessing risk of bias in randomised trials
- (2019) Jonathan A C Sterne et al. BMJ-British Medical Journal
- A 24-step guide on how to design, conduct, and successfully publish a systematic review and meta-analysis in medical research
- (2019) Taulant Muka et al. EUROPEAN JOURNAL OF EPIDEMIOLOGY
- ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions
- (2016) Jonathan AC Sterne et al. BMJ-British Medical Journal
- ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions
- (2016) Jonathan AC Sterne et al. BMJ-British Medical Journal
- A basic introduction to fixed-effect and random-effects models for meta-analysis
- (2010) Michael Borenstein et al. Research Synthesis Methods
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started